ATHIRA PHARMA INC. - COMMON STOCK
0.7064
14-十一月-24 10:00:31
15 分钟延时
股票
-0.0236
-3.23%
今日范围
0.6928 - 0.7472
ISIN
N/A
来源
NASDAQ
-
Athira Pharma Presents Preclinical Data at the Alzheimer's Association International Conference 2022
02 8月 2022 14:30:00 条件 Nasdaq GlobeNewswire
-
25 7月 2022 06:00:00 条件 Nasdaq GlobeNewswire
-
22 6月 2022 06:00:01 条件 Nasdaq GlobeNewswire
-
07 6月 2022 06:00:00 条件 Nasdaq GlobeNewswire
-
Shareholders Approve the Election of All Three Athira Director Nominees at 2022 Annual Meeting
19 5月 2022 11:06:13 条件 Nasdaq GlobeNewswire
-
Athira Issues Statement in Response to Richard A. Kayne’s Suspension of His Proxy Contest
16 5月 2022 15:49:31 条件 Nasdaq GlobeNewswire
-
Athira Pharma Presents Preclinical Data at the 2022 Peripheral Nerve Society (PNS) Annual Meeting
16 5月 2022 06:00:01 条件 Nasdaq GlobeNewswire
-
12 5月 2022 15:05:02 条件 Nasdaq GlobeNewswire
-
Athira Urges Shareholders to Support its Director Nominees at May 19 Annual Meeting
11 5月 2022 15:15:00 条件 Nasdaq GlobeNewswire
-
09 5月 2022 06:00:02 条件 Nasdaq GlobeNewswire
-
05 5月 2022 11:03:56 条件 Nasdaq GlobeNewswire
-
05 5月 2022 07:00:03 条件 Nasdaq GlobeNewswire
-
04 5月 2022 17:46:09 条件 Nasdaq GlobeNewswire
-
26 4月 2022 07:00:03 条件 Nasdaq GlobeNewswire
-
20 4月 2022 08:02:06 条件 Nasdaq GlobeNewswire
-
Athira Files Definitive Proxy Statement and Mails Letter to Shareholders
05 4月 2022 15:04:20 条件 Nasdaq GlobeNewswire
-
04 4月 2022 06:00:01 条件 Nasdaq GlobeNewswire
-
Athira Pharma Highlights Strong Execution of Strategy and Positioning for the Future
30 3月 2022 11:12:04 条件 Nasdaq GlobeNewswire
-
Athira Pharma Reports Full Year 2021 Financial Results and Provides Clinical Update
24 3月 2022 15:05:01 条件 Nasdaq GlobeNewswire
-
Athira Pharma Announces Appointment of Dr. Michael A. Panzara to its Board of Directors
21 3月 2022 06:05:00 条件 Nasdaq GlobeNewswire